-
Something wrong with this record ?
Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study
Robert Opavský, Petr Hluštík, Pavel Otruba, Petr Kaňovský
Language English Country England, Great Britain
Document type Journal Article
Grant support
NS9920
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 1997-01-01 to 1 year ago
- MeSH
- Botulinum Toxins, Type A pharmacology therapeutic use MeSH
- Adult MeSH
- Injections, Intramuscular methods MeSH
- Neck Muscles drug effects innervation physiopathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neuromuscular Agents pharmacology therapeutic use MeSH
- Somatosensory Cortex physiopathology MeSH
- Somatosensory Disorders drug therapy physiopathology MeSH
- Torticollis drug therapy physiopathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Converging data on focal dystonias suggest a widespread disorder of somatosensory processing. The aims of our study were, first, to assess somatosensory activation patterns in cervical dystonia (CD) beyond the representation of the affected body parts and, second, to search for task-related activation changes induced by botulinum toxin type-A (BoNT-A) therapy. Functional magnetic resonance imaging (MRI) during electrical median nerve stimulation was employed in seven CD patients and nine controls; the examination was repeated 4 weeks after BoNT-A application to dystonic neck muscles. The pretreatment activation map of patients showed activation in the contralateral primary somatosensory cortex, but missing activation in the secondary somatosensory cortex and insula, in contrast to controls and patients after treatment. Clinically significant effect of BoNT-A therapy was associated with a significant increase of BOLD response in the contralateral secondary somatosensory, insular, and inferior parietal cortices. The posttreatment somatosensory maps of patients did not significantly differ from controls. This study has brought evidence of widespread disruption of somatosensory processing in CD and its modification with BoNT-A therapy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034900
- 003
- CZ-PrNML
- 005
- 20160729151708.0
- 007
- ta
- 008
- 121023s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/00207454.2011.623807 $2 doi
- 035 __
- $a (PubMed)21919815
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Opavský, Robert, $d 1974- $7 xx0140752 $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic. robert.opavsky@centrum.cz
- 245 10
- $a Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study / $c Robert Opavský, Petr Hluštík, Pavel Otruba, Petr Kaňovský
- 520 9_
- $a Converging data on focal dystonias suggest a widespread disorder of somatosensory processing. The aims of our study were, first, to assess somatosensory activation patterns in cervical dystonia (CD) beyond the representation of the affected body parts and, second, to search for task-related activation changes induced by botulinum toxin type-A (BoNT-A) therapy. Functional magnetic resonance imaging (MRI) during electrical median nerve stimulation was employed in seven CD patients and nine controls; the examination was repeated 4 weeks after BoNT-A application to dystonic neck muscles. The pretreatment activation map of patients showed activation in the contralateral primary somatosensory cortex, but missing activation in the secondary somatosensory cortex and insula, in contrast to controls and patients after treatment. Clinically significant effect of BoNT-A therapy was associated with a significant increase of BOLD response in the contralateral secondary somatosensory, insular, and inferior parietal cortices. The posttreatment somatosensory maps of patients did not significantly differ from controls. This study has brought evidence of widespread disruption of somatosensory processing in CD and its modification with BoNT-A therapy.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a botulotoxiny typu A $x farmakologie $x terapeutické užití $7 D019274
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a injekce intramuskulární $x metody $7 D007273
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a krční svaly $x účinky léků $x inervace $x patofyziologie $7 D009334
- 650 _2
- $a nervosvalové látky $x farmakologie $x terapeutické užití $7 D009465
- 650 _2
- $a somatosenzorické korové centrum $x patofyziologie $x radioizotopová diagnostika $7 D013003
- 650 _2
- $a somatosenzorické poruchy $x farmakoterapie $x patofyziologie $x radioizotopová diagnostika $7 D020886
- 650 _2
- $a tortikolis $x farmakoterapie $x patofyziologie $x radioizotopová diagnostika $7 D014103
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hluštík, Petr, $d 1964- $7 xx0074066 $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Otruba, Pavel $7 xx0119392 $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Kaňovský, Petr, $d 1961- $7 jn20000620150 $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 773 0_
- $w MED00011505 $t The International journal of neuroscience $x 1563-5279 $g Roč. 122, č. 1 (2012), s. 45-52
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21919815 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20160729151510 $b ABA008
- 999 __
- $a ok $b bmc $g 956910 $s 792397
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 122 $c 1 $d 45-52 $i 1563-5279 $m International Journal of Neuroscience $n Int J Neurosci $x MED00011505
- GRA __
- $a NS9920 $p MZ0
- LZP __
- $b NLK112 $a Pubmed-20121023